MEIS1 and acute lymphoblastic leukemia: Analysis of an additional dataset for BCP-ALL patients (GSE10792) confirmed widespread expression of IRX1 and restricted activities of IRX3 to subtypes ETV6 and KMT2A, and of MEIS1 to subtype KMT2A (Figure S3).